Cargando…

Dose-response meta-analysis of differences in means

BACKGROUND: Meta-analytical methods are frequently used to combine dose-response findings expressed in terms of relative risks. However, no methodology has been established when results are summarized in terms of differences in means of quantitative outcomes. METHODS: We proposed a two-stage approac...

Descripción completa

Detalles Bibliográficos
Autores principales: Crippa, Alessio, Orsini, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971698/
https://www.ncbi.nlm.nih.gov/pubmed/27485429
http://dx.doi.org/10.1186/s12874-016-0189-0
_version_ 1782446152154611712
author Crippa, Alessio
Orsini, Nicola
author_facet Crippa, Alessio
Orsini, Nicola
author_sort Crippa, Alessio
collection PubMed
description BACKGROUND: Meta-analytical methods are frequently used to combine dose-response findings expressed in terms of relative risks. However, no methodology has been established when results are summarized in terms of differences in means of quantitative outcomes. METHODS: We proposed a two-stage approach. A flexible dose-response model is estimated within each study (first stage) taking into account the covariance of the data points (mean differences, standardized mean differences). Parameters describing the study-specific curves are then combined using a multivariate random-effects model (second stage) to address heterogeneity across studies. RESULTS: The method is fairly general and can accommodate a variety of parametric functions. Compared to traditional non-linear models (e.g. E(max), logistic), spline models do not assume any pre-specified dose-response curve. Spline models allow inclusion of studies with a small number of dose levels, and almost any shape, even non monotonic ones, can be estimated using only two parameters. We illustrated the method using dose-response data arising from five clinical trials on an antipsychotic drug, aripiprazole, and improvement in symptoms in shizoaffective patients. Using the Positive and Negative Syndrome Scale (PANSS), pooled results indicated a non-linear association with the maximum change in mean PANSS score equal to 10.40 (95 % confidence interval 7.48, 13.30) observed for 19.32 mg/day of aripiprazole. No substantial change in PANSS score was observed above this value. An estimated dose of 10.43 mg/day was found to produce 80 % of the maximum predicted response. CONCLUSION: The described approach should be adopted to combine correlated differences in means of quantitative outcomes arising from multiple studies. Sensitivity analysis can be a useful tool to assess the robustness of the overall dose-response curve to different modelling strategies. A user-friendly R package has been developed to facilitate applications by practitioners.
format Online
Article
Text
id pubmed-4971698
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49716982016-08-04 Dose-response meta-analysis of differences in means Crippa, Alessio Orsini, Nicola BMC Med Res Methodol Research Article BACKGROUND: Meta-analytical methods are frequently used to combine dose-response findings expressed in terms of relative risks. However, no methodology has been established when results are summarized in terms of differences in means of quantitative outcomes. METHODS: We proposed a two-stage approach. A flexible dose-response model is estimated within each study (first stage) taking into account the covariance of the data points (mean differences, standardized mean differences). Parameters describing the study-specific curves are then combined using a multivariate random-effects model (second stage) to address heterogeneity across studies. RESULTS: The method is fairly general and can accommodate a variety of parametric functions. Compared to traditional non-linear models (e.g. E(max), logistic), spline models do not assume any pre-specified dose-response curve. Spline models allow inclusion of studies with a small number of dose levels, and almost any shape, even non monotonic ones, can be estimated using only two parameters. We illustrated the method using dose-response data arising from five clinical trials on an antipsychotic drug, aripiprazole, and improvement in symptoms in shizoaffective patients. Using the Positive and Negative Syndrome Scale (PANSS), pooled results indicated a non-linear association with the maximum change in mean PANSS score equal to 10.40 (95 % confidence interval 7.48, 13.30) observed for 19.32 mg/day of aripiprazole. No substantial change in PANSS score was observed above this value. An estimated dose of 10.43 mg/day was found to produce 80 % of the maximum predicted response. CONCLUSION: The described approach should be adopted to combine correlated differences in means of quantitative outcomes arising from multiple studies. Sensitivity analysis can be a useful tool to assess the robustness of the overall dose-response curve to different modelling strategies. A user-friendly R package has been developed to facilitate applications by practitioners. BioMed Central 2016-08-02 /pmc/articles/PMC4971698/ /pubmed/27485429 http://dx.doi.org/10.1186/s12874-016-0189-0 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Crippa, Alessio
Orsini, Nicola
Dose-response meta-analysis of differences in means
title Dose-response meta-analysis of differences in means
title_full Dose-response meta-analysis of differences in means
title_fullStr Dose-response meta-analysis of differences in means
title_full_unstemmed Dose-response meta-analysis of differences in means
title_short Dose-response meta-analysis of differences in means
title_sort dose-response meta-analysis of differences in means
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971698/
https://www.ncbi.nlm.nih.gov/pubmed/27485429
http://dx.doi.org/10.1186/s12874-016-0189-0
work_keys_str_mv AT crippaalessio doseresponsemetaanalysisofdifferencesinmeans
AT orsininicola doseresponsemetaanalysisofdifferencesinmeans